← Database
M&A

VINPAI

Acquired by

CAMLIN FINE SCIENCES

FRANCE Food Processing EV [1m EUR - 100m EUR] 11/2025

Target

VINPAI

Acquirer

CAMLIN FINE SCIENCES

Context

Camlin Fine Sciences (CFSL) completed the acquisition of a 78.68% majority stake in Vinpai from existing shareholders. Following this block acquisition, CFSL will convert its convertible bonds on December 1, 2025, increasing its ownership to 83.82%. Consistent with French market regulations, CFSL intends to file a simplified mandatory tender offer (OPAS) in mid-December 2025 for the remaining shares at the same price. If the 90% ownership threshold is reached, a squeeze-out (retrait obligatoire) will be implemented to delist Vinpai from Euronext Growth.

The transaction values VINPAI at an EV/Revenue multiple of LOGIN.

This transaction is part of the AgriFood industry, which currently tracks an average EBITDA multiple of 10.1x since the beginning of 2026, 9.8% decrease compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in AgriFood market trends

Target

Vinpai is a French technology-driven ingredients company specializing in the design and manufacture of functional ingredients derived from algae, plants, minerals, and fibers. The company provides Corporate manufacturers in the food, cosmetics, and nutraceutical sectors with natural alternatives to chemical additives. With two production sites in Brittany and near Saint-Nazaire, Vinpai has developed a library of over 3,500 formulas. The company focuses heavily on international markets, with over 70% of its revenue generated through exports to more than 36 countries.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples Analysis

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2025
LOGIN
LOGIN
LOGIN
2024
LOGIN
LOGIN
LOGIN

Other operations with VINPAI

mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.